FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and pharmaceutics, namely to the use of a pharmaceutical composition for inducing body weight reduction and/or reduction of body fat of the patient with pre-fattening, obesity or pathological obesity, where the pharmaceutical composition contains an effective amount of a compound of the following structure: 
, 
, 
, 
, 
, 
or 
or its pharmaceutically acceptable salt and pharmaceutically acceptable carrier.
EFFECT: invention provides a wider range of products for reducing body weight and/or reducing body fat.
13 cl, 47 dwg, 1 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS FOR TREATING OBESITY, AND METHODS FOR USING THEM | 2013 |
|
RU2768868C2 |
| COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF | 2013 |
|
RU2650646C2 |
| AMPK LOW-MOLECULAR ACTIVATORS | 2017 |
|
RU2766146C2 |
| OBESITY TREATMENT | 2019 |
|
RU2822679C2 |
| NEW N-SULFAMOYLPIPERIDINEAMIDS DESIGNED FOR PREVENTION OR TREATMENT OF FATTY DEGENERATION AND CONGENEROUS PATHOLOGICAL CONDITIONS | 2006 |
|
RU2442773C2 |
| METHODS AND COMPOSITIONS TO IMPROVE COGNITIVE FUNCTIONS | 2012 |
|
RU2792010C2 |
| NOVEL PHARMACEUTICAL USE OF THIENO[3,2-D]PYRIMIDIN-4-ONE COMPOUNDS | 2019 |
|
RU2768828C1 |
| AZOLES AS INHIBITORS OF MALONYL-COA-DECARBOXYLASE USEFUL AS METABOLIC MODULATING AGENTS | 2002 |
|
RU2258706C2 |
| AMINOTETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS FOR TREATING OR PREVENTING DIABETES | 2010 |
|
RU2550508C2 |
| SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2513636C2 |
